XML 55 R44.htm IDEA: XBRL DOCUMENT v3.22.1

Long-Term Investments (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
BioFirst [Member]
Long-Term Investments (Details) [Line Items]
Percentage of common stock shares	15.99%	15.99%
Additional shares issued (in Shares)	663,798	684,720
Rgene [Member]
Long-Term Investments (Details) [Line Items]
Percentage of common stock shares	31.62%	31.62%

X

- References

No definition available.

+ Details

Name:	abvc_LongTermInvestmentsDetailsLineItems
Namespace Prefix:	abvc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of excess stock shares of an entity that have been sold or granted to shareholders.

+ References

No definition available.

+ Details

Name:	us-gaap_ExcessStockSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioFirstCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_RgeneCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: